Today, FDA issued an emergency use authorization (EUA) for the third vaccine for the prevention of #COVID19 caused by SARS-CoV-2. The EUA allows the vaccine to be distributed in the U.S for use in individuals 18 years and older. fda.gov/news-events/pr…
“The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for #COVID19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States.” – Acting FDA Commissioner @DrWoodcockFDA
@US_FDA "analysis of vaccine efficacy against moderate to severe/critical and severe/critical COVID-19 was done for the United States, South Africa, and Brazil. There was a lower efficacy against moderate to severe/critical disease endpoints observed in South Africa"-Janssen Briefing doc
@US_FDA Johnson & Johnson / Janssen adds to vaccine supply with a product that has a vaccine efficacy of 66.1% vs 94.1% and 95% for the Moderna and Pfizer BioNTech products. 72.0% in US trials. Janssen had efficacy of 85.4% against severe/critical disease. Deaths were in placebo group.
@US_FDA Revelation 13:16-17 And he causeth all, both small and great, rich and poor, free and bond, to receive a mark in their right hand, or in their foreheads: And that no man might buy or sell, save he that had the mark, or the name of the beast, or the number of his name.
@US_FDA Mr. Zeller, The FDA is approving drugs, device and procedures overnight for the Covid-19 crisis. Why hasn't the FDA approving 22nd Century's MRTP for VLN cigarettes to help in the crisis that kills 20,000 people worldwide each day?